Xiaoyu Yang

Title: Innovations of Xiaoyu Yang in Monoclonal Antibodies

Introduction

Xiaoyu Yang is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of monoclonal antibodies, particularly in the development of crystals that can be utilized in cancer treatment. His work has implications for advancing therapeutic options in oncology.

Latest Patents

Xiaoyu Yang holds a patent for "Crystals of anti-human PD-1 monoclonal antibodies." This patent includes crystals of pembrolizumab and structurally similar anti-PD-1 monoclonal antibodies. The invention also outlines methods for producing these crystals and their applications in treating cancers. Notably, the method described produces crystals suitable for X-ray diffraction, which were used to determine the three-dimensional structure of pembrolizumab at a resolution of 2.3 Å.

Career Highlights

Xiaoyu Yang is associated with Merck Sharp & Dohme Corporation, where he has been involved in groundbreaking research and development. His work has contributed to the understanding and application of monoclonal antibodies in medical treatments.

Collaborations

Xiaoyu has collaborated with esteemed colleagues, including Paul Reichert and Winifred W. Prosise, who have also contributed to advancements in the field of monoclonal antibodies.

Conclusion

Xiaoyu Yang's innovative work in the development of monoclonal antibody crystals represents a significant advancement in cancer treatment. His contributions continue to influence the field and pave the way for future research and applications.